Clinical trial
Fenretinide in Treating Children With Solid Tumors
NCT00003191 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00003191 |
|---|---|
| Title | Fenretinide in Treating Children With Solid Tumors |
| Official title | A Phase I Study of Fenretinide (NSC #374551) in Children With High Risk Solid Tumors |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neuroblastoma, Unspecified Childhood Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | fenretinide |
| Enrollment | 18 |
| Start date | Mar 1, 1998 |
| Primary completion | Mar 1, 2005 |
| First posted | Nov 26, 2003 |
| Last update posted | Feb 7, 2013 |
| Countries | Australia, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: